# Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention

> **NCT03378934** · PHASE4 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 64 (estimated)

## Conditions studied

- Coronary Artery Disease
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Berberine
- **DRUG:** Standard treatment
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT03378934
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-09-26
- **Primary completion:** 2026-06
- **Final completion:** 2026-08
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378934, "Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03378934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*